Oruka Therapeutics Inc. (ORKA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Oruka Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: In Vitro & In Vivo Diagnostic Substances
Price
$95.97
+0.17% today
Market cap
$6.3B
Overall quality
—
Kronos AI 30-day
−9.7%
1 of 8 simulated paths end higher
Oruka Therapeutics Inc. (ORKA) is a Health Care company in Biotechnology: In Vitro & In Vivo Diagnostic Substances, worth $6.3B. It trades at $95.97, up 0.17% today. 11 analysts' average target of $151.90 implies +58.3% from today's price. Kronos AI's 30-day forecast is −9.7% (1 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $151.90 |
| Low – high | $105.00 – $200.00 |
| Analysts | 11 |
| Upside to average | +58.3% |
Kronos AI 30-day forecast
| Expected close | $86.51 (−9.7%) |
| Likely range | −12.9% … −5.8% |
| As of | 2026-10-27 |
1 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: In Vitro & In Vivo Diagnostic Substances
For information only, not investment advice. Prices updated: 2026-10-29.